Kobayashi Pharmaceutical Co., Ltd. (TYO:4967)
Japan flag Japan · Delayed Price · Currency is JPY
5,824.00
-25.00 (-0.43%)
May 13, 2026, 3:30 PM JST

Kobayashi Pharmaceutical Ratios and Metrics

Millions JPY. Fiscal year is Jan - Dec.
Fiscal Year
CurrentFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
May '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
434,807403,511463,131503,841650,295704,427
Market Cap Growth
6.29%-12.87%-8.08%-22.52%-7.69%-28.53%
Enterprise Value
370,515346,251412,429409,238545,580602,944
Last Close Price
5849.005428.006110.346545.868584.518506.77
PE Ratio
141.72110.3746.0124.7732.4835.73
Forward PE
37.6530.3730.1124.5233.4634.40
PS Ratio
2.612.442.802.913.914.54
PB Ratio
2.081.912.172.463.293.60
P/TBV Ratio
2.262.082.402.753.523.85
P/FCF Ratio
-32.71-89.9137.8837.56
P/OCF Ratio
-15.7741.1827.4420.3831.42
PEG Ratio
0.722.43-20.4313.3911.08
EV/Sales Ratio
2.222.092.492.363.283.88
EV/EBITDA Ratio
16.3914.6812.6012.9217.1219.59
EV/EBIT Ratio
27.0923.3216.6915.9720.5823.23
EV/FCF Ratio
-28.07-73.0331.7832.15
Debt / Equity Ratio
0.000.000.000.010.000.00
Debt / EBITDA Ratio
0.030.030.030.030.020.02
Debt / FCF Ratio
-0.06-0.180.050.03
Net Debt / Equity Ratio
-0.31-0.33-0.30-0.38-0.52-0.55
Net Debt / EBITDA Ratio
-2.84-2.96-1.98-2.49-3.26-3.52
Net Debt / FCF Ratio
--5.674.38-14.07-6.04-5.78
Asset Turnover
0.660.610.620.660.650.63
Inventory Turnover
3.023.453.373.884.514.55
Quick Ratio
2.352.042.482.372.943.24
Current Ratio
3.042.483.112.823.343.59
Return on Equity (ROE)
1.48%1.72%4.81%10.10%10.18%10.43%
Return on Assets (ROA)
3.37%3.43%5.80%6.12%6.52%6.61%
Return on Invested Capital (ROIC)
7.88%10.02%13.03%17.18%20.94%21.02%
Return on Capital Employed (ROCE)
6.40%6.90%11.30%12.10%13.00%12.90%
Earnings Yield
0.71%0.91%2.17%4.04%3.08%2.80%
FCF Yield
-3.06%-3.20%1.11%2.64%2.66%
Dividend Yield
1.82%1.92%1.67%1.54%1.05%0.98%
Payout Ratio
-209.33%74.55%35.52%32.51%31.71%
Buyback Yield / Dilution
--1.98%1.67%1.27%0.05%
Total Shareholder Return
1.82%1.92%3.65%3.21%2.32%1.03%
Source: S&P Global Market Intelligence. Standard template. Financial Sources.